Dr. Mark Mofid brings back safety into plastic surgery

Dr. Mark Mofid is one of the best plastic surgeons in the United States. His reputation as a plastic surgeon is huge. On Yelp, he has a rating of five and a half stars and the reviews show that his clients are happy with the services he provided. Reputation in this kind of sensitive industry is a priority. Plastic surgery is one of the hardest careers one can join since it involves performing intricate medical operations which if gone wrong can easily mess the health of the clients. Many are times when we have heard of plastic surgeries that have gone wrong, and patients are left with huge defects on their bodies. Most of these cases happen as a result of malpractice or medical accidents.

Whenever a client is looking for a surgeon to attend to his or her body, the reputation of the doctor should be one of the things you look at. You want to see how many successful surgeries has he had before you commit yourself to him or her. Luckily some plastic surgeons have created a good name in the industry. One of them is Dr. Mark Mofid. He is one of the doctors who has delivered many surgeries to his clients without a problem. He recently even ventured into gluteal augmentation which has been the hardest surgery for many doctors. Dr. Mark Mofid is doing it successfully, and therefore patents looking for such services now have a reliable surgeon to attend to them.

Dr. Mark Mofid is doing another thing in his medical practice. He is not only using the implants which have been discovered before to treat his patients, but he is involved in research work where he is creating implants which have perfect results. In the field of gluteal augmentation, he has created an implant that does not leave any hanging muscle as it used to happen before with other implants. Dr. Mark Mofid has created a name as a surgeon who prioritizes the safety of the patient. It is not about how much you can afford to buy but about does it fit your body?


Dr. Mark McKenna Wants to Make Getting Botox Easier

Did you ever want to get a botox treatment but you thought that there was too much hassle involved? That is all changed now, thanks to Dr. Mark McKenna and his new company, OVME.

Dr. Mark McKenna studied at Tulane Medical School, but he decided to go into real estate instead of opening a private medical practice. He was successful, but after Hurricane Katrina struck, he lost all that he had. He started and sold new businesses, including a fitness and gym chain. He is now working on OVME.

This is something that is entirely new and exciting. Instead of having to visit a doctor or plastic surgeon, you can get a botox call to your house. The app will allow anyone across the country to order a botox call. The botox will be administered by freelancers who are trained and certified. The company will dedicate itself to high quality and the same kind of user experience across the board. This way, users all over the country will be able to get botox treatments that are associated with a country-wide brand.

In an interview with IdeaMensch, as well as in another interview with Forbes Magazine, Dr. Mark McKenna said that the idea for OVME came to him after he was working in the medical aesthetics industry for ten years. He realized that the botox industry did not have a streamlined process for getting botox treatments from a trusted provider. You had to go to individual doctors and plastic surgeons, and each one was different. With OVME, you can get an experience that is similar to Uber, only in a different industry.

Dr. Mark McKenna said that he made a lot of money in real estate, but that after Hurricane Katrina, he was left with nothing. He ended up starting Shapemed, which is a company that he eventually sold for a lot of money. He said that the decline of smoking in the United States is one trend that excites him. He also said that he reads a lot of books and that it helps him be a better entrepreneur.


Eric Lefkofsky-Ambitious Entrepreneur

Almost 40 percent of adults living in the United States has a cancer diagnosis, and most people can say that they know at least one person who has cancer or who has beat cancer. In 2014 alone, at least 14.5 million Americans have cancer, and that figure is expected to climb up to over 19 million by 2024.

Tempus, co-founded by Eric Lefkofsky, is taking the reins when it comes to data-enabled medicine. The healthcare industry does not have everything under complete control as it may seem and is quite the opposite. There are overwhelming amounts of data collected on patients and all of their treatments but no effective or efficient way to handle it all. That’s where companies such as Tempus come in. Tempus is changing the way that care is delivered, and they have come up with a way to develop better analytics software. However, they are faced with some challenges such as providing medical data that is both affordable and accessible.

Tempus has also had to deal with how information is gotten and stored on patients. The physician notes that they have to work with can be difficult to process, but the software that they developed have made it possible to handle the workload. Tempus is helping to lower the cost of sequencing and is helping to make progress in combating cancer.

Tempus is making it possible for doctors to pair their cancer patients with the proper treatments and to make better treatment decisions.

Eric Lefkofsky is not only the co-founder and CEO of Tempus, but he is also the co-founder of Groupon. He graduated from the University of Michigan and he has also obtained his Juris Doctor degree. He is also the founding partner of Lightbank and co-founder of Uptake Technologies. He also established the Lefkofsky Foundation in 2006.

Eric Lefkofsky is on the board of directors of the Art Institute of Chicago, and of Lurie’s Children’s Memorial Hospital in Chicago. Lefkofsky has also taught at the Kellstadt Graduate School of business, and he is the professor at the University of Chicago’s Booth School of Business.

For More info: lefkofskyfoundation.com/about-eric-lefkofsky/